One Month Dual Antiplatelet Therapy With Ticagrelor in Coronary Artery Bypass Graft Patients
Status: Recruiting
Location: See all (23) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The purpose of this study is to compare the effect of ticagrelor plus low-dose aspirin versus low-dose aspirin alone in patients with chronic coronary disease undergoing coronary artery bypass grafting.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥18 years
• Elective first-time CABG with use of ≥1 saphenous vein graft;
• Ability to sign informed consent and comply with all study procedures, including follow-up for at least 5 years.
Locations
United States
New Jersey
Englewood Hospital
RECRUITING
Englewood
New York
NewYork-Presbyterian: Queens Hospital
RECRUITING
Flushing
Weill Cornell Medicine
RECRUITING
New York
Other Locations
Austria
Medical University Graz
RECRUITING
Graz
Medical University Innsbruck
RECRUITING
Innsbruck
Johannes Kepler University Linz
RECRUITING
Linz
Medical University of Vienna
RECRUITING
Vienna
Canada
University of Ottawa Heart Institute
NOT_YET_RECRUITING
Ottawa
China
Beijing Anzhen Hospital
RECRUITING
Beijing
Center China Fuwai Hospital
RECRUITING
Beijing
Jilin Heart Hospital
RECRUITING
Changchun
Ruijin Hospital: Shanghai Jiao Tong University School of Medicine
RECRUITING
Shanghai
Germany
University Hospital of Düsseldorf
RECRUITING
Düsseldorf
Westdeutsches Herz- und Gefäßzentrum Essen, Universität Duisburg-Essen
NOT_YET_RECRUITING
Essen
Klinik für Herz- und Gefäßchirurgie - Universitäts-Herzzentrum Freiburg - Bad Krozingen
NOT_YET_RECRUITING
Freiburg Im Breisgau
Universitätsklinikum Giessen
NOT_YET_RECRUITING
Giessen
Jena University Hospital
RECRUITING
Jena
University Hospital Giessen and Marburg
RECRUITING
Marburg
LMU Klinikum Campus Großhadern
NOT_YET_RECRUITING
München
Robert-Bosch-Krankenhaus Stuttgart
NOT_YET_RECRUITING
Stuttgart
Sweden
Sahlgrenska University Hospital
RECRUITING
Gothenburg
Sahlgrenska University Hospital Sweden
NOT_YET_RECRUITING
Gothenburg
Skåne University Hospital
RECRUITING
Malmo
Contact Information
Primary
Trisha Ali-Shaw
tra2002@med.cornell.edu
646-962-8281
Time Frame
Start Date: 2024-08-15
Estimated Completion Date: 2031-01
Participants
Target number of participants: 700
Treatments
Experimental: Ticagrelor 90 mg + Low-Dose Aspirin
Active_comparator: Low-Dose Aspirin Alone
Related Therapeutic Areas
Sponsors
Collaborators: Canadian Institutes of Health Research (CIHR)
Leads: Weill Medical College of Cornell University